Table 12.6c

Immunosuppression Use: Maintenance Between Discharge

and One Year Posttransplant, 1993 to 2002

Recipients with Lung Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants		674	738	893	836	946	893	920	977	1,083	1,054
Tx With Follow-up Immunosuppression Info		530	526	638	573	680	661	666	734	799	826
Corticosteroids	Category Usage	98.9%	98.1%	99.1%	99.3%	98.4%	99.5%	99.7%	98.9%	99.5%	97.0%
	Steroids	98.9%	98.1%	99.1%	99.3%	98.4%	99.5%	99.7%	98.9%	99.5%	97.0%
Cyclosporine	Category Usage	91.1%	81.2%	70.5%	70.0%	62.2%	64.4%	64.1%	54.8%	45.7%	35.2%
	Cyclosporin	90.6%	71.7%	1.1%	0.0%	0.0%	0.0%	0.0%	0.3%	0.0%	0.0%
	Sandimmmune	3.4%	8.0%	35.4%	14.5%	8.4%	6.7%	4.5%	4.2%	5.0%	2.5%
	Neoral	0.2%	2.7%	37.5%	56.4%	55.0%	58.7%	59.3%	49.2%	35.2%	26.8%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.5%	2.9%	7.0%	7.4%
	Eon	0.0%	0.0%	0.0%	0.2%	0.0%	0.0%	0.3%	0.1%	0.1%	0.1%
Tacrolimus	Category Usage	9.6%	12.0%	23.4%	33.9%	37.8%	41.8%	47.0%	55.9%	69.1%	75.7%
	FK506	9.6%	12.0%	23.4%	33.9%	37.8%	41.8%	47.0%	55.9%	69.1%	75.7%
Antimetabolites	Category Usage	97.7%	96.0%	90.4%	88.7%	88.5%	92.3%	92.0%	94.6%	91.2%	88.7%
	Azathioprine	97.4%	94.5%	79.3%	68.4%	57.6%	62.3%	58.3%	53.5%	48.4%	43.7%
	Mycophenolate mofetil	0.2%	1.5%	12.7%	23.9%	32.9%	37.4%	41.1%	49.0%	52.7%	53.9%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.3%	0.0%
	Cytoxan	0.6%	0.8%	0.6%	0.3%	0.6%	0.2%	0.3%	0.7%	0.3%	0.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	6.0%	6.3%	11.0%	14.4%
	Rapamycin	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	6.0%	6.3%	11.0%	14.4%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.